Revia
Formulated to support abstinence in recovery programs to target cravings for substances.
Strengths: 50mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Adepend
- Therapeutic class
Opioid antagonist
- Pharmacological class
Opioid antagonist
- Minor side effects
nausea; dizziness; headache
- Moderate side effects
insomnia; anxiety; abdominal pain
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Bristol-Myers Squibb
- Onset Time
1 hour
- Duration
24 hours
- Storage instructions
Store securely below 25°C; keep out of reach of children.
- Drug interactions
opioid-containing analgesics; cough suppressants
- Age restrictions
Not recommended for patients under 18 years.
Contraindications
acute hepatitis; liver failure; current opioid dependence; positive urine screen for opioids
Precautions and warnings
must be opioid-free before starting therapy; monitor liver function regularly; alert physicians if emergency opioid analgesia is required
Serious side effects
hepatotoxicity — requires immediate medical attention; depression — requires immediate medical attention
Patient summary
Formulated to support abstinence in recovery programs to target cravings for substances.
Mechanism of action
It acts as a competitive opioid receptor antagonist, effectively binding to brain opioid receptors to block the euphoric effects of opioids and alcohol.
Pregnancy and breastfeeding
Pregnancy: Only use if strictly necessary. Breastfeeding: Seek medical advice before use.
Revia
Formulated to support abstinence in recovery programs to target cravings for substances.
Editorial Notes
- Active ingredient(s): Naltrexone
- Listed indication(s): Alcohol Dependence, Opioid Dependence
Available option
- 20 tablets - 50 mg649-50-mg-1445